Azitra (AZTR) Return on Invested Capital (2023 - 2026)
Azitra's (AZTR) quarterly Return on Invested Capital came in at 2.09% in Q1 2026, down 115.0% YoY from 13.91% in Q1 2025, and down 38.36% on a QoQ basis from 1.51% in Q4 2025.
Azitra (AZTR) Return on Invested Capital (2023 - 2026) Analysis & Trends
Azitra (AZTR) has 4 years of Return on Invested Capital data on file, last reported at 2.09% in Q1 2026.
- Quarterly Return on Invested Capital fell 115.0% year-over-year to 2.09% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.09% (down 115.0% YoY) and the FY2025 annual result came in at 6.05%, down 276.0% from the prior year.
- Return on Invested Capital fell to 2.09% in Q1 2026, from 1.51% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.73% in Q2 2024 to a low of 2.09% in Q1 2026.
- A 4-year average of 1.12% and a median of 1.01% in 2025 frame the typical range for Return on Invested Capital.
- Annual changes were most pronounced in 2024 — Return on Invested Capital soared 34 bps — and 2026, when it slumped 115 bps.
- Tracing AZTR's Return on Invested Capital over 4 years: stood at 1.16% in 2023, then climbed by 29 bps to 0.82% in 2024, then sank by 84 bps to 1.51% in 2025, then slumped by 38 bps to 2.09% in 2026.
- The last three Return on Invested Capital figures came in at 2.09% (Q1 2026), 1.51% (Q4 2025), and 1.26% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Azitra | 2.53 Mn | 2.53 Mn | - | -3.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.09% |
| Mar 31, 2026 | -2.09% |
| Dec 31, 2025 | -1.51% |
| Sep 30, 2025 | -1.26% |
| Jun 30, 2025 | -1.09% |
| Mar 31, 2025 | -0.93% |
| Dec 31, 2024 | -0.82% |
| Sep 30, 2024 | -0.74% |
| Jun 30, 2024 | -0.73% |
| Mar 31, 2024 | -0.86% |
| Dec 31, 2023 | -1.16% |